Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 2790-2793, July 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darbre, P. D.
Right arrow Articles by King, R. J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darbre, P. D.
Right arrow Articles by King, R. J. B.

Effects of Estradiol and Tamoxifen on Human Breast Cancer Cells in Serum-free Culture

Philippa D. Darbre, Sally Curtis and R. J. B. King1

Hormone Biochemistry Department, Imperial Cancer Research Fund, Lincoln's Inn Fields, P. O. Box 123, London WC2A 3PX, England

ZR-75-1 human mammary cancer cells can be grown in serumfree medium in an estradiol- and tamoxifen-sensitive manner. Growth occurs both in monolayer and suspension culture, although serum is necessary during the initial plating of the cells in monolayer culture. Optimal stimulation of proliferation by estradiol occurs at 10-8 and 10-9 M. Tamoxifen alone weakly stimulated growth in a dose-dependent manner up to 10-7 M, but inhibition was observed at 10-6 M. This inhibition was not seen if the cells were cultured in 10% dextran:charcoal-treated fetal calf serum. This difference is ascribed to tamoxifen binding components in the serum.

In the absence of serum, tamoxifen (10-6 M) abolished the proliferative effect of estradiol at all concentrations of estradiol below 10-7 M. Higher concentrations of estradiol partially overcame the tamoxifen effect. Consistent antiestrogenic effects of tamoxifen required an estradiol:tamoxifen ratio of 1:1000.

1 To whom requests for reprints should be addressed.

Received 1/10/84. Accepted 3/30/84.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Caltagirone, F. O. Ranelletti, A. Rinelli, N. Maggiano, A. Colasante, P. Musiani, F. B. Aiello, and M. Piantelli
Interaction with Type II Estrogen Binding Sites and Antiproliferative Activity of Tamoxifen and Quercetin in Human Non-Small-Cell Lung Cancer
Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 51 - 59.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. Gundimeda, Z.-H. Chen, and R. Gopalakrishna
Tamoxifen Modulates Protein Kinase C via Oxidative Stress in Estrogen Receptor-negative Breast Cancer Cells
J. Biol. Chem., June 7, 1996; 271(23): 13504 - 13514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.